Gilead Sciences | 净收入

股票价格
152.16
每天变化
2.79 1.87%
每月一次
22.36%
每年
58.43%
Q1 预测
137.58




净收入 更改 日
AbbVie USD 1.82B 1.63B 2025-12
Agios Pharmaceuticals USD -103.43M 8.59M 2025-09
ALKERMES USD 82.76M 4.34M 2025-09
Alnylam Pharmaceuticals USD 251.08M 317.36M 2025-09
Amgen USD 1.33B 1.88B 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -30.74M 271.28M 2025-09
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 3.05B 1.09B 2025-09
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Incyte USD 424.17M 19.17M 2025-09
J&J USD 5.12B 36M 2025-12
Merck USD 2.96B 2.82B 2025-12
Moderna USD -200M 625M 2025-09
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 3.93B 96M 2025-09
Pfizer USD -1.65B 5.19B 2025-12
PTC Therapeutics USD 15.9M 80.75M 2025-09
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Sanofi EUR -801M 3.6B 2025-12
Sarepta Therapeutics USD -179.95M 376.84M 2025-09
United Therapeutics USD 338.7M 29.2M 2025-09
Vertex Pharmaceuticals USD 1.08B 50M 2025-09


Gilead Sciences 净收入 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.